InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT06005194
- Status
- Recruiting
Conditions
- Clinical Depression
- Depressive Disorder, Major
- Mood Depressed
- Physical Inactivity
- TBI (Traumatic Brain Injury)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- InMotion — BEHAVIORALA manualized physical activity counseling program that is based on the Diabetes Prevention Program (DPP) that has been adapted for TBI
Study Details
The purpose of this randomized controlled trial is to evaluate whether the InMotion intervention, delivered via telehealth (using a HIPAA-compliant video platform or phone), which uses evidence-based behavioral and motivational counseling to increase daily physical activity, is an effective treatment for Major Depressive Disorder (MDD) for people who are at least one year out from sustaining a traumatic brain injury (TBI). The first aim is to compare the efficacy of the InMotion intervention to the waitlist control (WLC) condition on measures of depression severity and associated conditions in under-active adults with TBI and MDD. For the second aim the investigators plan to identify possible moderators of exercise treatment effects. The third aim will examine possible mediators of treatment outcome. In addition, the weekly dose of exercise, the extent to which exercise generates positive affect, and engagement in enjoyable or meaningful aspects of life will be explored.
Key Dates
- Start date
- Nov 14, 2023
- Status verified
- Sep 2024
- Primary completion
- Dec 31, 2026
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Wait List Control (WLC) ConditionThe WLC control condition entails following usual care and includes the ability to participate in the intervention at the 12 week-end point for the intervention group. The WLC condition is based on equity considerations; the investigators want all participants to have access to treatment. Equity is especially important given our plans to over-enroll African American persons given statistically increased barriers to access care.
- Active Comparator: InMotion Intervention ConditionThe intervention consists of a manualized physical activity counseling program and includes motivational interviewing over a HIPAA-compliant telehealth delivery model. There will be 8 counseling sessions over 12 weeks. Sessions will be 30-90 minutes long and scheduled during weeks 1-4, 6, 8, 10, and 12. The Fitbit Charge 5 will be set up to sync with the participants' internet-connected device to share activity data with the physical activity coach /interventionist to monitor progress and tailor treatment goals. Given the InMotion intervention was designed to treat Major Depressive Disorder (MDD) in Traumatic Brain Injury (TBI), the intervention will be delivered by a mental health provider (licensed masters level social worker/MSW) with training and supervision in behavioral aspects of exercise promotion and supervised by a psychologist (who is also the study Principal Investigator) and a physical therapist.
Primary Outcome Measure
Hopkins Symptom Checklist-20 (SCL-20) [ Time Frame: Baseline ]
Central Contacts
- Erica Wasmund206 897 6322
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Washington Medical Center | Seattle | Washington | 98105 | Erica Wasmund Silas James, MPA Charles Bombardier, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Seattle, WA
Related Studies
- Increasing Physical Activity for Adults With Multiple Sclerosis (MS)Recruiting · University of Washington · Seattle, Washington
- Promoting Physical Activity in Older Hispanic/Latino(a) AdultsRecruiting · Kaiser Permanente · San Diego, California
- Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPHASE3 · Recruiting · Janssen Research & Development, LLC · Birmingham, Alabama
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderPHASE3 · Recruiting · Eli Lilly and Company · Moorpark, California